MBIO - mustangbio.com Debt to Book Capitalization Ratio

Mustang Bio, Inc. (MBIO) is protected by a patent barrier and exclusive licenses for gene therapy. The company's debt-to-book capitalization ratio demonstrates financial leverage dynamics, with the indicator standing at 0.00. While the scientific platform ensures global scalability of products, the current liquidity shortage and research costs are forcing the business to divest assets to cover operating expenses.

Mustang Bio, Inc. (MBIO) gene therapy development is independent of market cycles but requires constant R&D funding. The 0.00 metric is calculated as the ratio of total liabilities to the book value of equity. This ratio determines the level of financial leverage and the risk of business insolvency. A decrease in this indicator minimizes the probability of bankruptcy, although it may limit the growth rate of returns. The historical trend of the debt-to-book capitalization ratio clearly demonstrates the stability of the company's capital structure.